These results suggest that AMPK activation can inhibit SARS-CoV-2 entry in cells expressing low amounts of TMPRSS2 and elucidate the observed correlation between fasting blood glucose and the severity of COVID-19 in patients, even without diagnosed diabetes [44,45]. The gene discussed is TMPRSS2; the disease is diabetes mellitus.